INFINIUM PHARMACHEM LTD Share Price

INFINIUM PHARMACHEM LTD Share Price

NSE: INFINIUM
|
Chemicals
|
S Cap
₹ 239.75
+₹6.00 (2.57%)
1D
Last updated 14 Aug, 2026, 09:39 IST

INFINIUM PHARMACHEM LTD Share Price Today

As of 15 Aug 2026, INFINIUM PHARMACHEM LTD share price is ₹239.75. The stock opened at ₹245.50, compared to its previous close of ₹233.75. During today's trading session, INFINIUM PHARMACHEM LTD share price moved in the range of ₹235.75 to ₹245.50, with an average price of ₹240.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹189.40 and a high of ₹276.00. On the performance front, INFINIUM PHARMACHEM LTD share price has increased by 9.00% over the last six months and is down 5.11% on a year-on-year basis.

₹235.75
2.57% up today
₹245.50
1D LOW
1D HIGH

INFINIUM PHARMACHEM LTD Returns Calculator

Circuit
L
H
₹210.40
₹257.10
52-week
L
H
₹189.40
₹276.00

About INFINIUM PHARMACHEM LTD

INFINIUM PHARMACHEM LTD Share Price
ISIN
INE0MRE01011
Sector Market Cap
₹ 376.96 Cr

Infinium Pharmachem Limited is an India-based company. The Company is engaged in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. Its portfolio includes approximately 200+ Iodine Derivatives and seven Active Pharmaceutical Ingredients (APIs). It manufactures and supplies a range of Iodine-based APIs, but on an Order-to-Made basis only. It offers Bulk Actives, intermediates and services for custom synthesis. It also provides contract research and manufacturing services to pharmaceutical and biotech companies for their diverse requirements of Iodine-based APIs and intermediates to reduce their research time and project cost. It manufactures iodine derivatives for various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, sanitation, agrochemical, electronics, nylon production, and other industries for their range of industrial applications.

INFINIUM PHARMACHEM LTD Financial Highlights

  • Revenue: INFINIUM PHARMACHEM LTD reported revenue of ₹191.77 crore in FY26 vs ₹157.83 crore in FY25. It showed an increase of 21.50% on a yearly basis.
  • Operating Profit: INFINIUM PHARMACHEM LTD reported an operating profit of ₹17.84 crore in FY26 vs ₹11.57 crore in FY25. It showed an increase of 54.19% on a year-on-year basis.
  • Net Profit: INFINIUM PHARMACHEM LTD reported a net profit of ₹14.20 crore in FY26 vs ₹7.84 crore in FY25. It showed an increase of 81.12% on a yearly basis.
Know more
Promoters
64.91%
FII
0.00%
Other DII
0.22%
Retail and other
34.87%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Nov 20240.00%
Mar 20250.00%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
376.96
P/E
36.35
P/B
3.15
ROE
8.66%
D/E
0.00
ROCE
13.37%
Div. Yield
0.00%
EPS(TTM)
6.43
Turnover
1.32
EV/EBITDA
—
Net Margin
0.00%
Op. Margin
0.00%
ROA
—
Quick Ratio
0.00
Curr. Ratio
4.20
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Infinium Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Infinium Pharma appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Infinium Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,66,155.0038.475.5813.74%0.6117.33%93.240.82%0.4810.90
Divis Laboratories2,25,648.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,84,109.0086.0322.0625.49%1.6913.85%222.760.69%0.4958.70
Cipla1,17,139.0035.173.4311.27%0.0014.95%423.360.89%0.4543.52
Zydus Lifesciences1,17,007.0025.484.3218.59%0.3117.35%237.300.09%0.3335.38
Lupin1,03,380.0018.624.6123.76%0.0424.88%659.050.80%0.57129.18
Dr. Reddy's Laboratories1,00,662.0031.622.6411.07%0.1812.54%377.960.66%0.4138.68
Mankind Pharma99,862.4048.306.1311.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,215.6025.932.549.25%0.1911.76%391.140.24%0.3841.58

INFINIUM PHARMACHEM LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹155.71₹135.64₹114.22₹99.12
Other Income₹2.12₹1.54₹1.35₹0.93
Total Revenue₹157.83₹137.18₹115.58₹100.05
Total Expenses₹146.26₹121.97₹102.62₹91.42
Profit Before Tax₹11.57₹15.21₹12.95₹8.63
Tax₹3.73₹3.71₹3.14₹1.95
Profit After Tax₹7.84₹11.50₹9.82₹6.69
EPS - Basic₹5.60₹8.12₹6.82₹60.07
EPS - Diluted₹5.60₹8.12₹6.82₹60.07

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹11.57₹15.21₹12.95₹8.63
Income before WC changes₹18.95₹20.01₹17.06₹10.39
Change in Assets-₹51.98-₹7.77-₹7.10-₹14.75
Change in Liabilities₹7.77-₹21.61₹1.75₹18.11
Change in WC-₹44.21-₹29.38-₹5.35₹3.36
Cash flow from Operations-₹29.12-₹13.04₹8.59₹11.80
Cash flow from Investing-₹27.24-₹3.79-₹4.96-₹6.63
Cash flow from Financing₹79.29₹22.77-₹3.10-₹1.70
Total Cash Flow₹22.93₹5.93₹0.53₹3.46
Cash (Start of the year)₹11.91₹5.98₹5.45₹1.99
Cash (End of the year)₹34.84₹11.91₹5.98₹5.45

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹58.47₹20.44₹19.30₹15.32
Current Assets₹139.92₹65.01₹51.31₹43.68
Total Assets₹198.39₹85.45₹70.61₹59.00
Current Liabilities₹63.59₹17.41₹36.77₹31.45
Net Current Asset₹76.33₹47.60₹14.54₹12.23
Non-Current Liabilities₹10.00₹7.81₹10.06₹13.62
Equity Capital₹124.80₹60.23₹23.78₹13.92
Total Equity & Liabilities₹198.39₹85.45₹70.61₹59.00

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹136.92₹122.36₹101.31₹74.04
Other Income₹2.13₹1.63₹1.34₹0.93
Total Revenue₹139.05₹123.98₹102.65₹74.96
Total Expenses₹127.44₹109.12₹90.38₹67.56
Profit Before Tax₹11.61₹14.86₹12.26₹7.41
Tax₹3.14₹3.77₹3.12₹1.90
Profit After Tax₹8.47₹11.09₹9.15₹5.50
EPS - Basic₹5.82₹7.97₹18.00₹54.13
EPS - Diluted₹5.82₹7.97₹18.00₹54.13

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹11.61₹14.86₹12.26₹7.41
Income before WC changes₹17.18₹18.77₹16.54₹9.62
Change in Assets-₹42.95-₹11.36-₹8.30-₹11.32
Change in Liabilities₹3.08-₹18.79₹2.21₹12.74
Change in WC-₹39.87-₹30.16-₹6.09₹1.43
Cash flow from Operations-₹25.95-₹15.03₹7.35₹9.14
Cash flow from Investing-₹23.15-₹3.29-₹2.58-₹7.17
Cash flow from Financing₹74.21₹23.19-₹3.00-₹1.66
Total Cash Flow₹25.11₹4.86₹1.77₹0.31
Cash (Start of the year)₹8.18₹3.32₹1.54₹1.24
Cash (End of the year)₹33.29₹8.18₹3.32₹1.54

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹37.84₹17.51₹16.41₹15.12
Current Assets₹128.29₹60.23₹44.00₹33.93
Total Assets₹166.13₹77.74₹60.42₹49.06
Current Liabilities₹55.84₹14.57₹31.09₹22.88
Net Current Asset₹72.45₹45.66₹12.92₹11.05
Non-Current Liabilities₹4.58₹5.42₹7.63₹13.62
Equity Capital₹105.71₹57.75₹21.70₹12.55
Total Equity & Liabilities₹166.13₹77.74₹60.42₹49.06
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
3
Neutral
4
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.97
Neutral
ATR (14)
8.32
Neutral
STOCH(9,6)
79.38
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
26.72
Bearish
UO(9)
49.23
Neutral
ROC(12)
13.42
Bullish
WillR(14)
-20.63
Neutral
Period
Simple value
Exponential vaue
5D
223.23
224.11
10D
214.86
218.39
20D
211.55
214.03
50D
208.97
211.07
100D
209.11
211.35
Volume trend — traded volume by day
14 Aug0L
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
Average0L
Compare against other stocks
INFINIUM PHARMACHEM LTD Share Price
INFINIUM PHARMACHEM LTD
Chemicals
Add Stock
Add Another

INFINIUM PHARMACHEM LTD Share Price FAQs